See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 22, 2006

Chronic Lymphocytic Leukemia Idiopathic Short Stature Schizophrenia and Schizoaffective Disorders

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Chronic Lymphocytic Leukemia

Volunteers 18 or older with B-cell chronic lymphocytic leukemia who have not been treated for the disease with a cell-depleting aim may be eligible for this clinical trial.

The research sites are in California, New York, and Texas.

More information

Please see


Idiopathic Short Stature

This study will evaluate a drug for treating idiopathic short stature (ISS) in children who don't grow to a height within normal range, but who are otherwise physically normal. Children without chronic disease ages 3-9 for girls and ages 3-10 for boys may qualify.

The research site is in New Hyde Park, NY.

More information

Please see


Schizophrenia and Schizoaffective Disorders

This study will evaluate an investigational medication to treat schizophrenia and schizoaffective disorder. Candidates at least 18 who were diagnosed a year ago or more with schizophrenia or schizoaffective disorder, have not been hospitalized for the condition within the last three months, and are taking either Seroquel (quetiapine) OR Risperdal (risperidone) and still have symptoms may be included.

The research site is in Stanford, Calif.

More information

Please see


Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.